Project MILANO: Connections Between Patients With Brain Tumors and Their Pets: an Analysis of Concerns and Needs
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Mar 26, 2025
Trial Information
Current as of May 09, 2025
Recruiting
Keywords
ClinConnect Summary
The Project MILANO clinical trial is focused on understanding the challenges and needs of patients with brain tumors who also have pets. Many people with brain tumors face difficulties in taking care of their pets due to declining health, which can lead to feelings of isolation and stress. This study aims to explore how these patients manage their pet care, especially during tough times like hospital stays or when facing serious health issues.
To be eligible for this study, participants must be diagnosed with a brain tumor and own at least one pet. The trial is currently looking for volunteers, and anyone who joins will share their experiences through a questionnaire. This research is important because it will help identify the specific needs of patients with brain tumors regarding their pets and may lead to better support solutions for both patients and their furry companions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with a brain tumor.
- • Patients who own at least one pet.
- Exclusion Criteria:
- • Patients who decline to participate in the study.
- • Patients unable to complete the questionnaire.
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint étienne, , France
Patients applied
Trial Officials
Carole Ramirez, Md
Principal Investigator
CHU de SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported